In cooperation with Reuters News and Reuters Health, we are proud to provide you with our continuously updated news feed. We select news that applies to physicians in all the major clinical specialties, as well as on finance, science, technology, and other areas.

Omicron variant may have picked up a piece of common-cold virus

By Nancy Lapid NEW YORK (Reuters) - The Omicron variant of the virus that causes COVID-19 likely acquired at least one of its mutations by picking up a snippet of genetic material from another virus -

Pre-eclampsia/eclampsia tied to increased risk of heart failure for at least 10 years

By Marilynn Larkin NEW YORK (Reuters Health) - Women with pre-eclampsia/eclampsia were at increased risk for future heart failure (HF) for up to a decade in a large cohort study. "While preeclampsia

Fat cell alterations implicated in breast cancer metastases

By Marilynn Larkin NEW YORK (Reuters Health) - In preclinical experiments, researchers have uncovered a mechanism linking fat cells altered by type 2 diabetes or insulin resistance to breast cancer

At least one year on bisphosphonates needed for fracture prevention

By Lisa Rapaport (Reuters Health) - It takes 12.4 months of bisphosphonate therapy to prevent one nonvertebral fracture per 100 postmenopausal women with osteoporosis, a meta-analysis of randomized

REUTERS NEXT-Researcher questions China's population data, says it may be lower

By Jane Lanhee Lee (Reuters) - China may be downplaying how fast its population is shrinking, and a recent policy to promote three-child families has poor chances to improve birth rates, a fertility

FDA clears use of Lilly's COVID-19 antibody therapy for kids

By Reuters Staff (Reuters) - The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly's COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children,

EXPLAINER-Could the Omicron variant bring milder illness?

By Deena Beasley (Reuters) - The Omicron variant, spreading now in southern Africa and detected in over 30 other countries, has prompted fears it could significantly undermine the effectiveness of

Omicron outbreak at Norway Christmas party is biggest outside S. Africa -authorities

By Gwladys Fouche and Nerijus Adomaitis OSLO (Reuters) - At least 13 people in Oslo have been infected with the Omicron variant of the coronavirus following a corporate Christmas party described as a

Valneva says no conclusions should be drawn on its vaccine from UK booster study

By Reuters Staff PARIS (Reuters) - French biotech firm Valneva said on Friday no conclusions should be drawn on the effectiveness of its COVID-19 vaccine by a British study, which found it was the

Artificial heart maker Carmat suspends implants due to quality issue

By Reuters Staff (Reuters) - French medical device company Carmat on Friday said it had suspended implants of its Aeson artificial hearts following a quality issue affecting some of its prostheses. "

Researchers find 'promising' blood biomarkers for cognitive decline in dementia

By Lorraine L. Janeczko NEW YORK (Reuters Health) - In dementia with Lewy bodies (DLB), plasma levels of phosphorylated-tau - p-tau181 and p-tau231 - may be accessible, cost-effective biomarkers for

Roche develops new research test kits for Omicron variant

By Brenna Hughes Neghaiwi ZURICH (Reuters) - Roche's newly acquired subsidiary TIB Molbiol has developed three new test kits to help researchers detect mutations in the new Omicron variant of

Bayer's Nubeqa drug improves survival in prostate cancer trial

By Ludwig Burger FRANKFURT (Reuters) - Bayer said a combination therapy including its Nubeqa drug was shown to prolong the lives of men suffering from metastatic prostate cancer in a clinical study,

IDSA advises eye protection as part of health worker PPE for suspected or known COVID patients

By Reuters Staff NEW YORK (Reuters Health) - In updated guidance, the Infectious Disease Society of America (IDSA) suggests that healthcare personnel caring for patients with suspected or known COVID-

Few doctor's offices provide accommodations for patients with significant vision impairment

By Linda Carroll NEW YORK (Reuters Health) - Just 10% of doctor's offices in the U.S. provide two basic accommodations - describing the clinic space and offering materials in large font - for patients

Lowering of CRC-screening age likely to affect colonoscopy demand, case mix, adenoma detection

By Reuters Staff NEW YORK (Reuters Health) - The recent lowering of colorectal cancer (CRC)-screening age from 50 to 45 years is likely to affect demand for colonoscopy and case mix, and result in a

Genetic subtype of lymphoma determines ibrutinib response

By Matthew Phelan NEW YORK (Reuters Health) - Younger patients with two genetic subtypes of diffuse large B-cell lymphoma (DLBCL) - MCD and N1 - had a three-year survival of 100% in the phase-3

Experimental malaria vaccine continues to show promise

By Reuters Staff NEW YORK (Reuters Health) - A study conducted in West Africa confirms the protective efficacy of an experimental malaria vaccine against naturally occurring infection and shows it can

Italian anti-vaxxer tries to get COVID-19 jab in fake arm

By Reuters Staff ROME (Reuters) - An Italian man turned up at a vaccination centre wearing a fake silicone arm, hoping to fool a nurse into giving him a jab in order to obtain a COVID-19 health

England's COVID-19 prevalence rises, led by Delta not Omicron

By Reuters Staff LONDON (Reuters) - The prevalence of COVID-19 infections in England rose to around 1 in 60 people in the week ending Nov. 27, Britain's Office for National Statistics said on Friday,

Geneva places 2,000 people in quarantine after two Omicron cases

By Brenna Hughes Neghaiwi ZURICH (Reuters) - The Swiss cantons of Geneva and Vaud have placed 2,000 people, most of them children, into quarantine after two cases of the Omicron variant were detected

REUTERS NEXT-WHO chief scientist says Omicron 'quite infectious', must not panic

By Francesco Guarascio and Stephanie Nebehay (Reuters) - The World Health Organization's chief scientist Soumya Swaminathan told the Reuters Next conference on Friday that while the new coronavirus

UK study finds mRNA COVID-19 vaccines provide biggest booster impact

By Alistair Smout LONDON (Reuters) - COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second dose, a

Verubecestat promising for glioblastoma

By Marilynn Larkin NEW YORK (Reuters Health) - Verubecestat, a beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) inhibitor originally developed to treat Alzheimer's disease, showed promise

Extracoronary vascular events likely rare after spontaneous coronary artery dissection

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with spontaneous coronary artery dissection (SCAD), severe vascular events were rare in a case series with five-year follow-up. "SCAD is a

Enriched infant formula does not improve later academic performance

By Lisa Rapaport (Reuters Health) - Giving infants nutritionally enriched baby formula won't lead to better grades in English or math during adolescence, a recent study suggests. Researchers examined

Omicron COVID-19 variant found in three U.S. states

By Kanishka Singh and Susan Heavey (Reuters) - Three U.S. states have found cases of the Omicron coronavirus variant -- California, Colorado and Minnesota -- among patients who were fully vaccinated

ANALYSIS-Trump's U.S. Supreme Court appointees poised to deliver on abortion

By Andrew Chung and Lawrence Hurley WASHINGTON (Reuters) - The month before being elected president in 2016, Donald Trump promised during a debate with his opponent Hillary Clinton to name justices to

S.Africa's health body sees threefold higher risk of reinfection from Omicron

By Reuters Staff JOHANNESBURG (Reuters) - The new Omicron variant of the coronavirus poses a threefold higher risk of reinfection than the currently dominant Delta variant and the Beta strain, a group

EU regulator begins real-time review of Valneva's COVID-19 shot

By Reuters Staff (Reuters) - The European Union's drug regulator said on Thursday it had started a rolling review of the inactivated-virus COVID-19 vaccine from French biotech firm Valneva, weeks

UPDATE 1-Israel halts disputed Omicron tracing through phone surveillance

(Recasts for halt to practice, updates case figures) By Reuters Staff JERUSALEM (Reuters) - Israel said on Thursday it was halting the use of mobile phone tracing to curb the spread of the new

FACTBOX-U.S. Omicron plan: boosters, free at-home tests, tighter travel rules

By Reuters Staff WASHINGTON (Reuters) - The Biden administration is seeking to ramp up its pandemic response amid the official arrival of the Omicron coronavirus variant, laying out a plan on Thursday

UPDATE 1-Omicron may become dominant in Europe in months -EU

(Adds details throughout) By Reuters Staff BRUSSELS (Reuters) - The European Union's public health agency said on Thursday that the Omicron variant could be responsible for more than half of all COVID

Psoriasis tied to small increase in risk of venous thromboembolism, peripheral vascular disease

By Linda Carroll NEW YORK (Reuters Health) - Venous thromboembolism (VTE) and peripheral vascular disease (PVD) may be slightly more likely to develop among patients with psoriasis than those without

Second U.S. Omicron variant case identified in Minnesota

By Reuters Staff (Reuters) - A case of the Omicron coronavirus variant was identified in Minnesota on Thursday, the U.S. state's health department said, with the identification coming a day after the

'Milestone' in stem-cell-based islet replacement for type-1 diabetes

By Reuters Staff NEW YORK (Reuters Health) - Interim results from an ongoing multicenter clinical trial show that implanted pluripotent-stem-cell-derived endocrine progenitor cells can secrete insulin

SPECIAL REPORT-U.S. rushed contracts to COVID-19 suppliers with troubled plants

By Marisa Taylor WASHINGTON (Reuters) - As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to

Israel's top court rejects petition against Omicron phone tracking

By Reuters Staff JERUSALEM (Reuters) - Israel's Supreme Court on Thursday rejected a petition by rights groups seeking to repeal temporary measures allowing the domestic intelligence agency to use

Third mRNA vaccine dose boosts immunity against SARS-CoV-2 variants in transplant recipients

By Lorraine L. Janezko NEW YORK (Reuters Health) - In organ transplant recipients, a third dose of the Moderna COVID-19 vaccine appears to increase neutralizing antibody response against SARS-CoV-2

Moderate COVID-19 infection in pregnancy unlikely to harm the fetal brain

By Megan Brooks NEW YORK (Reuters Health) - Mild to moderate COVID-19 infection during pregnancy appears to have no harmful effect on the brain of the developing fetus, according to a small study. "

Prenatal alcohol exposure alters fetal brain structure

By Megan Brooks NEW YORK (Reuters Health) - Radiologists observed significant changes in the brain structure of fetuses exposed to alcohol in the first MRI-based study to investigate the issue. "We

Finland to limit children's COVID-19 vaccines to high-risk households

By Essi Lehto HELSINKI (Reuters) - Children in Finland aged five and over should be vaccinated against COVID-19 if they or someone in their household are at high risk of severe infection, the Finnish

New Delhi shuts schools, colleges again due to air pollution

By Reuters Staff NEW DELHI (Reuters) - India's capital New Delhi has ordered the closure of schools and colleges until further notice from Friday after the Supreme Court criticised the city government

Omicron may soon cause over half of COVID infections in Europe -EU

By Reuters Staff BRUSSELS (Reuters) - The European Union's public health agency said on Thursday that the Omicron variant could be responsible for more than half of all COVID-19 infections in Europe

GSK says tests indicate antibody drug works against Omicron

By Ludwig Burger (Reuters) - Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new

S.Africa sees rise in COVID reinfections from Omicron, mild symptoms - scientist

By Katharine Houreld and Ayenat Mersie NAIROBI (Reuters) - South Africa is seeing an increase in COVID-19 reinfections due to the Omicron variant but symptoms for reinfected patients and those

Structured exercise aids arm function after breast cancer surgery

By Lisa Rapaport (Reuters Health) - Women who have non-reconstructive breast cancer surgery may experience better arm function when they follow a structured exercise program in addition to usual care,

Cytoreductive surgery beneficial when ovarian cancer recurs

By Reuters Staff NEW YORK (Reuters Health) - Adding cytoreductive surgery to chemotherapy can help women with recurrent ovarian cancer live nearly eight months longer than chemotherapy alone,

Biden seeks end to AIDS epidemic in the United States by 2030

By Jarrett Renshaw and Nandita Bose (Reuters) - U.S. President Joe Biden on Wednesday unveiled an updated national strategy to combat the AIDS epidemic with a goal of ending it by 2030. "We are within

Antihistamines linked to better immunotherapy response in cancer patients

By Marilynn Larkin NEW YORK (Reuters Health) - In cancer patients receiving immunotherapy, antihistamine drugs may improve outcomes, retrospective and preclinical analyses suggest. "We know some

Rituximab likely raises risk of hospital death in COVID-19 patients

By Marilynn Larkin NEW YORK (Reuters Health) - In hospitalized COVID-19 patients on immunosuppressive therapy, only those taking rituximab had an increased risk of in-hospital death in a retrospective

First known U.S. Omicron case found in fully vaccinated overseas traveler

By Trevor Hunnicutt WASHINGTON (Reuters) - The United States on Wednesday identified its first known case of Omicron, discovered in a fully vaccinated patient who traveled to South Africa, as

Moderna exec says company could have Omicron booster ready in March

By Michael Erman and Julie Steenhuysen NEW YORK (Reuters) - Moderna Inc could have a COVID-19 booster shot targeting the Omicron variant tested and ready to file for U.S. authorization as soon as

EXPLAINER-Does Omicron pose higher risks for infants than other variants?

By Alexander Winning and Tim Cocks JOHANNESBURG (Reuters) - Data from an area in South Africa hard-hit by the Omicron variant of the coronavirus has shown a high number of hospital admissions of

S.African data suggests Omicron gets around some, not all immunity

By Promit Mukherjee and Estelle Shirbon JOHANNESBURG (Reuters) - The Omicron variant appears able to get around some immunity but vaccines should still offer protection against severe disease,

U.S. Supreme Court conservatives lean toward limiting abortion

By Lawrence Hurley and Andrew Chung WASHINGTON (Reuters) - Conservative U.S. Supreme Court justices on Wednesday signaled support for curbing abortion rights in America by upholding a restrictive

UPDATE 1-Botswana's health director says majority of Omicron variant cases were asymptomatic

(Adds details, quote) By Promit Mukherjee JOHANNESBURG (Reuters) - A senior Botswana health official said on Tuesday that 16 out of the total 19 cases of the Omicron coronavirus variant detected in

Vaccine coverage below 10% in seven eastern Mediterranean nations - WHO

By Reuters Staff CAIRO (Reuters) - An official at the WHO's Eastern Mediterranean Regional Office said on Wednesday seven countries in the region have not yet reached a threshold of 10% vaccination

Botswana's health director says majority of Omicron variant cases were asymptomatic

By Reuters Staff JOHANNESBURG (Reuters) - A top official in Botswana's health ministry said on Tuesday that 16 out of the total 19 cases of the Omicron variant detected in the country were

High early amino acid intake in preemies might have positive brain effects

By Megan Brooks NEW YORK (Reuters Health) - For babies born before 30 weeks' gestation, high early amino acid intake is safe and associated with improved cognitive development at 5 years of age,

Colchicine may not cut risk of death from COVID-19: meta-analysis

By Linda Carroll NEW YORK (Reuters Health) - The gout drug colchicine does not appear to lessen COVID-19 severity or stave off death from the disease, according to a new meta-analysis that contradicts

Viral RNA in blood an early predictor of COVID-19 death

By Megan Brooks NEW YORK (Reuters Health) - The amount of viral RNA in blood can reliably identity patients who are at higher risk of dying from COVID-19, a new study suggests. "There is no need to

Older blood thinners tied to increased risk of delayed brain bleeds after head injury

By Megan Brooks NEW YORK (Reuters Health) - Patients taking clopidogrel or warfarin have a significantly higher risk of suffering delayed brain bleeding and dying following head trauma than peers

Activists rally as U.S. Supreme Court hears high-stakes abortion case

By Gabriella Borter, Julia Harte and Jan Wolfe WASHINGTON (Reuters) - Carrying signs and playing music, hundreds of people favoring and opposing abortion rights staged dueling rallies in front of the

REUTERS NEXT-COVID-19 took toll on AIDS fight, UNAIDS chief says

By Julie Steenhuysen CHICAGO (Reuters) - New infections and deaths from HIV/AIDS may increase as the COVID-19 pandemic has disrupted prevention measures, said UNAIDS Executive Director Winnie Byanyima

WHO agrees to launch talks on pact to tackle pandemics

By Stephanie Nebehay GENEVA (Reuters) - The World Health Organization (WHO) agreed on Wednesday to launch negotiations on an international pact to prevent and control future pandemics at a time when

White House says DOJ will defend government's authority to promote vaccine requirement

By Nandita Bose WASHINGTON (Reuters) - The White House said on Wednesday the U.S. Department of Justice "will vigorously defend" the government's authority to promote its vaccine requirement in

EU brings forward Pfizer/BioNTech COVID shot for younger children to Dec 13

By Andreas Rinke and Ludwig Burger FRANKFURT (Reuters)- The European Union-wide rollout of Pfizer and BioNTech's COVID-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week

Laparoscopic distal gastrectomy noninferior to open procedures for gastric cancer

By Lisa Rapaport (Reuters Health) - Patients with locally advanced gastric cancer have similar five-year overall survival outcomes with laparoscopic and open distal gastrectomy, a recent study

New York City opens first U.S. sites for supervised narcotics injection

By Maria Caspani NEW YORK (Reuters) - The first sites in the United States that allow narcotics users to inject drugs under the supervision of trained staff opened in New York City on Tuesday, a move

Fauci: Too soon to say if Omicron variant will lead to severe disease

By Jeff Mason and Ahmed Aboulenein (Reuters) - It is too early to know whether Omicron variant of COVID-19 will lead to severe disease, but preliminary information from South Africa indicates it does

Guselkumab boosts response in resistant psoriatic arthritis

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with psoriatic arthritis (PsA) who are resistant to tumor necrosis factor inhibitors (TNFi), guselkumab was more effective than placebo in a

Hospitalization for COVID-19 during pregnancy tied to increased rate of complications

By Linda Carroll NEW YORK (Reuters Health) - Pregnant women who are hospitalized for COVID-19 are more likely to have complications during pregnancy and birth, compared to those who don't catch the

Overtreatment of early papillary thyroid neoplasms continues, despite preventive strategies

By Marilynn Larkin NEW YORK (Reuters Health) - Strategies to prevent overtreatment of papillary thyroid carcinomas (PTCs) have had mixed success, a cohort study shows. "Both of our major findings

No support for calcium administration during out-of-hospital cardiac arrest

By Reuters Staff NEW YORK (Reuters Health) - Treatment with intravenous or intraosseous calcium during out-of-hospital cardiac arrest does not improve the likelihood of sustained return of spontaneous

Atezolizumab, nivolumab tied to longer survival than docetaxel in advanced lung cancer

By Lorraine L. Janeczko NEW YORK (Reuters Health) - Patients with advanced non-small-cell lung cancer (NSCLC) who are treated with atezolizumab or nivolumab appear to survive longer than those treated

Value of fourth COVID-19 vaccine shot in patients with solid-organ transplants questionable

By Megan Brooks NEW YORK (Reuters Health) - Giving solid-organ-transplant recipients a fourth dose of mRNA COVID-19 vaccine may lead to only a slight improvement in SARS-CoV-2 antibody concentrations

Study reveals spectrum of COVID-19 brain complications

By Megan Brooks NEW YORK (Reuters Health) - Brain complications including stroke and hemorrhage occur in about one in 100 hospitalized patients with COVID-19, new research suggests. "There should

BioNTech CEO says vaccine likely to protect against severe COVID from Omicron

By Ludwig Burger and Patricia Weiss FRANKFURT (Reuters) - BioNTech and Pfizer's COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant,

How South African scientists spotted the Omicron COVID variant

By Tim Cocks JOHANNESBURG (Reuters) - On Friday Nov. 19, Raquel Viana, Head of Science at one of South Africa's biggest private testing labs, sequenced the genes on eight coronavirus samples - and got

The race is on to trace the new COVID-19 variant

By Alistair Smout, Francesco Guarascio and Chen Lin LONDON/BRUSSELS/SINGAPORE (Reuters) - Governments around the world are urgently scouring databases for recent cases of COVID-19 infections,

Omicron variant could outcompete Delta, South African disease expert says

By Alexander Winning JOHANNESBURG (Reuters) - The Omicron coronavirus variant detected in southern Africa could be the most likely candidate to displace the highly contagious Delta variant, the

Hybrid closed-loop therapy boosts glycemic control in youth with type-1 diabetes

By Scott Baltic NEW YORK (Reuters Health) - In children and adolescents with type-1 diabetes, a hybrid closed-loop (HCL) system significantly improved glycemic control and quality of life compared

GSK names Pfizer scientist Dormitzer as vaccines R&D head

By Reuters Staff (Reuters) - GSK has hired one of the scientists behind Pfizer's mRNA COVID-19 shot, Phil Dormitzer, as its global head of R&D for vaccines and he will join the British drugmaker from

Mask mandates to tackle Omicron come into force in England

By Reuters Staff LONDON (Reuters) - New mask mandates and other measures aimed at curbing the spread of the Omicron coronavirus variant came into force in England on Tuesday, as Prime Minister Boris

WHO's Tedros warns against over-reaction to Omicron

By Stephanie Nebehay GENEVA (Reuters) - The head of the World Health Organization (WHO) voiced concern on Tuesday that some countries were introducing blanket measures against the Omicron coronavirus

Regeneron says its COVID-19 antibody drug could be less effective against Omicron

By Reuters Staff (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody treatment and other similar drugs could be less effective against the new Omicron coronavirus variant, the company said

Mercury exposure from seafood consumption not tied to cardiovascular and all-cause mortality in US

By Linda Carroll (Reuters Health) - People can enjoy the health benefits of seafood consumption without worrying that the mercury in the food will shorten their lives, a new study suggests. An

Judge blocks U.S. COVID-19 vaccine rule for health workers in 10 states

By Tom Hals (Reuters) - A federal judge on Monday blocked in 10 states a Biden administration vaccine requirement, finding the agency that issued the rule mandating healthcare workers get vaccinated

ABMS member boards follow parental, caregiver and medical leave mandate

By Lisa Rapaport (Reuters Health) - Specialty training programs two years or longer all follow a new American Board of Medical Specialties (ABMS) mandate for six weeks of parental, caregiver, or

Telehealth exercise and diet programs curb pain and boost function in knee osteoarthritis

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with knee osteoarthritis, telehealth-delivered exercise and diet programs are superior to electronic health information for reducing pain and

Certain gut microbiota more responsive to low FODMAP diet for IBS

By Marilynn Larkin NEW YORK (Reuters Health) - In patients with irritable bowel syndrome (IBS), those with certain gut microbiota species responded better to a low FODMAP diet, researchers suggest. A

Pubmed articles

In order to help keep you abreast of current research we offer our PubMed feed. This section features the most recently published peer-reviewed studies in the 10 most common disease states.

Medical Jobs

Search healthcare jobs by specialty or location.